Literature DB >> 6957277

Regulation of human immunoglobulin production in vitro by prostaglandin E2.

N D Staite, G S Panayi.   

Abstract

Human peripheral blood mononuclear cells (HPBMC) from healthy individuals were stimulated polyclonally with pokeweed mitogen (PWM), in vitro, to produce IgG and IgM, which were subsequently measured by enzyme linked immunosorbent assay (ELISA). Indomethacin at 10(-6)-10(-8)M inhibited both IgG and IgM production but only when added within the first 24 hr of culture. PWM-stimulated HPBMC produced prostaglandin E2 (PGE2) during the first 24 hr of culture and this was completely inhibited by 10(-6)M indomethacin. Exogenous PGE2 added to PWM-stimulated HPBMC produced variable effects on immunoglobulin production at relatively high concentration (10(-6)-10(-7)M). However, reversal of inhibition of IgG production caused by 10(-7)M indomethacin was achieved with approximately 10(-7)M PGE2 but indomethacin-mediated inhibition of IgM production could not be fully reversed. No effect of either PGE2 or indomethacin could be detected on the PWM-induced proliferative response. These results suggest that prostaglandin E2, possibly with other arachidonic acid products, may be involved in the regulation of immunoglobulin production.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6957277      PMCID: PMC1536666     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Control of mitogen-induced transformation: characterization of a splenic suppressor cell and its mode of action.

Authors:  D R Webb; T Jamieson
Journal:  Cell Immunol       Date:  1976-06-01       Impact factor: 4.868

Review 2.  Prostaglandins and the immune response.

Authors:  L M Pelus; H R Strausser
Journal:  Life Sci       Date:  1977-03-15       Impact factor: 5.037

3.  Macrophages synthesis and release prostaglandins in response to inflammatory stimuli.

Authors:  J L Humes; R J Bonney; L Pelus; M E Dahlgren; S J Sadowski; F A Kuehl; P Davies
Journal:  Nature       Date:  1977-09-08       Impact factor: 49.962

4.  Antigen stimulation of prostaglandin synthesis and control of immune responses.

Authors:  D R Webb; P L Osheroff
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

5.  Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.

Authors:  B Bresnihan; H E Jasin
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

6.  Radioimmunoassay for prostaglandins.

Authors:  B M Jaffe; J W Smith; W T Newton; C W Parker
Journal:  Science       Date:  1971-02-05       Impact factor: 47.728

7.  Indomethacin enhancement of spleen-cell responsiveness to mitogen stimulation in tumorous mice.

Authors:  L M Pelus; H R Strausser
Journal:  Int J Cancer       Date:  1976-11-15       Impact factor: 7.396

8.  Release of prostaglandin by mitogen- and antigen-stimulated leukocytes in culture.

Authors:  V A Ferraris; F R DeRubertis
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

9.  Subversion of immune system by tumor cells and role of prostaglandins.

Authors:  O J Plescia; A H Smith; K Grinwich
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

10.  Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors.

Authors:  L Shou; S A Schwartz; R A Good
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Control of humoral immune responses by arachidonic acid metabolites.

Authors:  T W Behrens; J S Goodwin
Journal:  Agents Actions       Date:  1989-01

2.  Cyclooxygenase-1 orchestrates germinal center formation and antibody class-switch via regulation of IL-17.

Authors:  Victoria A Blaho; Matthew W Buczynski; Edward A Dennis; Charles R Brown
Journal:  J Immunol       Date:  2009-11-01       Impact factor: 5.422

Review 3.  Effect of antipyretic analgesics on immune responses to vaccination.

Authors:  Ezzeldin Saleh; M Anthony Moody; Emmanuel B Walter
Journal:  Hum Vaccin Immunother       Date:  2016-05-31       Impact factor: 3.452

4.  Reversal of lipopolysaccharide-analog-induced antibody suppression by anti-transforming growth factor beta and indomethacin.

Authors:  M J Odean; A G Johnson; M Mohrman; A Hasegawa
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

5.  Changes in mononuclear cell function in patients with rheumatoid arthritis following treatment with auranofin.

Authors:  R J Coughlan; M B Richter; G S Panayi
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

Review 6.  Regulation of the immune response by prostaglandins.

Authors:  J S Goodwin; J Ceuppens
Journal:  J Clin Immunol       Date:  1983-10       Impact factor: 8.317

7.  Prostaglandin E2 suppresses phytohemagglutinin-induced immune responses of normal human mononuclear cells by decreasing intracellular glutathione generation, but not due to increased DNA strand breaks or apoptosis.

Authors:  C L Yu; C L Liu; C Y Tsai; K H Sun; T S Liao; W M Lin; H L Chen; H S Yu
Journal:  Agents Actions       Date:  1993-11

8.  Prostaglandin-mediated immunoregulation: reduced sensitivity of in vitro immunoglobulin production to indomethacin in rheumatoid arthritis.

Authors:  N D Staite; M Ganczakowski; G S Panayi; A Unger
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

9.  Regulation of human B cell activation by prostaglandin E2. Suppression of the generation of immunoglobulin-secreting cells.

Authors:  D F Jelinek; P A Thompson; P E Lipsky
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

10.  Primary in vitro antibody response in humans: role of adherent cells in the development of haemolytic colonies.

Authors:  M L Villa; G Rappocciolo; P Piazza
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.